Phase 2 Readout
INKT: Phase 2 Readout: agent-797
December 31, 2026 · agent-797. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- MiNK Therapeutics, Inc. (INKT)
- Drug
- agent-797
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: agent-797
- Drug
- agent-797
- Indication
- severe acute lung injury and respiratory distress